BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Argus Health
US Department of Justice

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,983,598

« Back to Dashboard

Summary for Patent: 4,983,598

Title: Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor
Abstract:Compositions of diltiazem and angiotensin-converting enzyme inhibitor useful for the treatment of hypertension, cardiac insufficiency and coronary insufficiency.
Inventor(s): Cavero; Icilio (Creteil, FR), Elkik; Francois (Paris, FR), Hicks; Peter (Cachan, FR), Muller; Jean-Claude (Morsang S/Orge, FR)
Assignee: Synthelabo (Paris, FR)
Application Number:07/195,151
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,983,598

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France86 16138Nov 20, 1986

International Patent Family for Patent: 4,983,598

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany3763582► Subscribe
France2607004► Subscribe
European Patent Office0272177► Subscribe
Denmark607387► Subscribe
Australia8140787► Subscribe
Canada1302268► Subscribe
Australia596712► Subscribe
Austria54253► Subscribe
Ireland873123► Subscribe
Ireland60594► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Fish and Richardson
Harvard Business School
Boehringer Ingelheim
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus